Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery


  • Based on the Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.


    In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.

    In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.

    In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.


    Key players in the global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market covered in Chapter 5:

    Pharmaceutical Product Development LLC

    Pfizer CentreSource

    Aenova Holding GmbH

    Jubilant Life Sciences Ltd.

    LSK Global Pharma Service Co Ltd.

    Patheon Inc.

    Catalent Inc.

    Recipharm AB

    Baxter Biopharma Solutions

    Lonza Group

    Novotech Pty Ltd.

    Boehringer Ingelheim Group

    Covance Inc.

    Famar SA

    Syneos Health Inc.

    PAREXEL International Corporation

    CMIC Holdings Co. Ltd


    In Chapter 6, on the basis of types, the Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market from 2015 to 2025 is primarily split into:

    Active Pharmaceutical Ingredient (API) Manufacturing

    Finished Dosage Formulation (FDF) Development

    and Manufacturing

    Secondary Packaging


    In Chapter 7, on the basis of applications, the Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market from 2015 to 2025 covers:

    Preclinical

    Phase I

    Phase II

    Phase III

    Phase IV


    Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:

    North America (Covered in Chapter 9)

    United States

    Canada

    Mexico

    Europe (Covered in Chapter 10)

    Germany

    UK

    France

    Italy

    Spain

    Russia

    Others

    Asia-Pacific (Covered in Chapter 11)

    China

    Japan

    South Korea

    Australia

    India

    South America (Covered in Chapter 12)

    Brazil

    Argentina

    Columbia

    Middle East and Africa (Covered in Chapter 13)

    UAE

    Egypt

    South Africa


    Years considered for this report:

    Historical Years: 2015-2019

    Base Year: 2019

    Estimated Year: 2020

    Forecast Period: 2020-2025

     

  • With tables and figures helping analyze worldwide Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

    Table of Content

    1 Market Overview

    1.1 Product Definition and Market Characteristics

    1.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size

    1.3 Market Segmentation

    1.4 Global Macroeconomic Analysis

    1.5 SWOT Analysis


    2. Market Dynamics

    2.1 Market Drivers

    2.2 Market Constraints and Challenges

    2.3 Emerging Market Trends

    2.4 Impact of COVID-19

    2.4.1 Short-term Impact
    2.4.2 Long-term Impact

    3 Associated Industry Assessment

    3.1 Supply Chain Analysis

    3.2 Industry Active Participants

    3.2.1 Suppliers of Raw Materials
    3.2.2 Key Distributors/Retailers

    3.3 Alternative Analysis

    3.4 The Impact of Covid-19 From the Perspective of Industry Chain


    4 Market Competitive Landscape

    4.1 Industry Leading Players

    4.2 Industry News

    4.2.1 Key Product Launch News
    4.2.2 M&A and Expansion Plans

    5 Analysis of Leading Companies

    5.1 Pharmaceutical Product Development LLC

    5.1.1 Pharmaceutical Product Development LLC Company Profile
    5.1.2 Pharmaceutical Product Development LLC Business Overview
    5.1.3 Pharmaceutical Product Development LLC Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
    5.1.4 Pharmaceutical Product Development LLC Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Products Introduction

    5.2 Pfizer CentreSource

    5.2.1 Pfizer CentreSource Company Profile
    5.2.2 Pfizer CentreSource Business Overview
    5.2.3 Pfizer CentreSource Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
    5.2.4 Pfizer CentreSource Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Products Introduction

    5.3 Aenova Holding GmbH

    5.3.1 Aenova Holding GmbH Company Profile
    5.3.2 Aenova Holding GmbH Business Overview
    5.3.3 Aenova Holding GmbH Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
    5.3.4 Aenova Holding GmbH Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Products Introduction

    5.4 Jubilant Life Sciences Ltd.

    5.4.1 Jubilant Life Sciences Ltd. Company Profile
    5.4.2 Jubilant Life Sciences Ltd. Business Overview
    5.4.3 Jubilant Life Sciences Ltd. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
    5.4.4 Jubilant Life Sciences Ltd. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Products Introduction

    5.5 LSK Global Pharma Service Co Ltd.

    5.5.1 LSK Global Pharma Service Co Ltd. Company Profile
    5.5.2 LSK Global Pharma Service Co Ltd. Business Overview
    5.5.3 LSK Global Pharma Service Co Ltd. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
    5.5.4 LSK Global Pharma Service Co Ltd. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Products Introduction

    5.6 Patheon Inc.

    5.6.1 Patheon Inc. Company Profile
    5.6.2 Patheon Inc. Business Overview
    5.6.3 Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
    5.6.4 Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Products Introduction
    5.7 Catalent Inc.
    5.7.1 Catalent Inc. Company Profile
    5.7.2 Catalent Inc. Business Overview
    5.7.3 Catalent Inc. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
    5.7.4 Catalent Inc. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Products Introduction
    5.8 Recipharm AB
    5.8.1 Recipharm AB Company Profile
    5.8.2 Recipharm AB Business Overview
    5.8.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
    5.8.4 Recipharm AB Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Products Introduction
    5.9 Baxter Biopharma Solutions
    5.9.1 Baxter Biopharma Solutions Company Profile
    5.9.2 Baxter Biopharma Solutions Business Overview
    5.9.3 Baxter Biopharma Solutions Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
    5.9.4 Baxter Biopharma Solutions Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Products Introduction

    5.10 Lonza Group

    5.10.1 Lonza Group Company Profile
    5.10.2 Lonza Group Business Overview
    5.10.3 Lonza Group Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
    5.10.4 Lonza Group Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Products Introduction
    5.11 Novotech Pty Ltd.
    5.11.1 Novotech Pty Ltd. Company Profile
    5.11.2 Novotech Pty Ltd. Business Overview
    5.11.3 Novotech Pty Ltd. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
    5.11.4 Novotech Pty Ltd. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Products Introduction
    5.12 Boehringer Ingelheim Group
    5.12.1 Boehringer Ingelheim Group Company Profile
    5.12.2 Boehringer Ingelheim Group Business Overview
    5.12.3 Boehringer Ingelheim Group Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
    5.12.4 Boehringer Ingelheim Group Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Products Introduction
    5.13 Covance Inc.
    5.13.1 Covance Inc. Company Profile
    5.13.2 Covance Inc. Business Overview
    5.13.3 Covance Inc. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
    5.13.4 Covance Inc. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Products Introduction
    5.14 Famar SA
    5.14.1 Famar SA Company Profile
    5.14.2 Famar SA Business Overview
    5.14.3 Famar SA Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
    5.14.4 Famar SA Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Products Introduction
    5.15 Syneos Health Inc.
    5.15.1 Syneos Health Inc. Company Profile
    5.15.2 Syneos Health Inc. Business Overview
    5.15.3 Syneos Health Inc. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
    5.15.4 Syneos Health Inc. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Products Introduction
    5.16 PAREXEL International Corporation
    5.16.1 PAREXEL International Corporation Company Profile
    5.16.2 PAREXEL International Corporation Business Overview
    5.16.3 PAREXEL International Corporation Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
    5.16.4 PAREXEL International Corporation Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Products Introduction
    5.17 CMIC Holdings Co. Ltd
    5.17.1 CMIC Holdings Co. Ltd Company Profile
    5.17.2 CMIC Holdings Co. Ltd Business Overview
    5.17.3 CMIC Holdings Co. Ltd Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
    5.17.4 CMIC Holdings Co. Ltd Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Products Introduction

    6 Market Analysis and Forecast, By Product Types

    6.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue and Market Share by Types (2015-2020)

    6.1.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Market Share by Types (2015-2020)
    6.1.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue and Market Share by Types (2015-2020)
    6.1.3 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Price by Types (2015-2020)

    6.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast by Types (2020-2025)

    6.2.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Sales and Market Share by Types (2020-2025)
    6.2.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Revenue and Market Share by Types (2020-2025)

    6.3 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Price and Growth Rate by Types (2015-2020)

    6.3.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Price and Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing
    6.3.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Price and Growth Rate of Finished Dosage Formulation (FDF) Development
    6.3.3 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Price and Growth Rate of and Manufacturing
    6.3.4 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Price and Growth Rate of Secondary Packaging

    6.4 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue and Sales Forecast, by Types (2020-2025)

    6.4.1 Active Pharmaceutical Ingredient (API) Manufacturing Market Revenue and Sales Forecast (2020-2025)
    6.4.2 Finished Dosage Formulation (FDF) Development Market Revenue and Sales Forecast (2020-2025)
    6.4.3 and Manufacturing Market Revenue and Sales Forecast (2020-2025)
    6.4.4 Secondary Packaging Market Revenue and Sales Forecast (2020-2025)

    7 Market Analysis and Forecast, By Applications

    7.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales, Revenue and Market Share by Applications (2015-2020)

    7.1.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Market Share by Applications (2015-2020)
    7.1.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue and Market Share by Applications (2015-2020)

    7.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast by Applications (2020-2025)

    7.2.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Sales and Market Share by Applications (2020-2025)
    7.2.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Revenue and Market Share by Applications (2020-2025)

    7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)

    7.3.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue, Sales and Growth Rate of Preclinical (2015-2020)
    7.3.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue, Sales and Growth Rate of Phase I (2015-2020)
    7.3.3 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue, Sales and Growth Rate of Phase II (2015-2020)
    7.3.4 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue, Sales and Growth Rate of Phase III (2015-2020)
    7.3.5 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue, Sales and Growth Rate of Phase IV (2015-2020)

    7.4 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue and Sales Forecast, by Applications (2020-2025)

    7.4.1 Preclinical Market Revenue and Sales Forecast (2020-2025)
    7.4.2 Phase I Market Revenue and Sales Forecast (2020-2025)
    7.4.3 Phase II Market Revenue and Sales Forecast (2020-2025)
    7.4.4 Phase III Market Revenue and Sales Forecast (2020-2025)
    7.4.5 Phase IV Market Revenue and Sales Forecast (2020-2025)

    8 Market Analysis and Forecast, By Regions

    8.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales by Regions (2015-2020)

    8.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue by Regions (2015-2020)

    8.3 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast by Regions (2020-2025)


    9 North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis

    9.1 Market Overview and Prospect Analysis

    9.2 North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Sales and Growth Rate (2015-2020)

    9.3 North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue and Growth Rate (2015-2020)

    9.4 North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast

    9.5 The Influence of COVID-19 on North America Market

    9.6 North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis by Country

    9.6.1 U.S. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate
    9.6.2 Canada Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate
    9.6.3 Mexico Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate

    10 Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis

    10.1 Market Overview and Prospect Analysis

    10.2 Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Sales and Growth Rate (2015-2020)

    10.3 Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue and Growth Rate (2015-2020)

    10.4 Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast

    10.5 The Influence of COVID-19 on Europe Market

    10.6 Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis by Country

    10.6.1 Germany Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate
    10.6.2 United Kingdom Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate
    10.6.3 France Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate
    10.6.4 Italy Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate
    10.6.5 Spain Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate
    10.6.6 Russia Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate

    11 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis

    11.1 Market Overview and Prospect Analysis

    11.2 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Sales and Growth Rate (2015-2020)

    11.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue and Growth Rate (2015-2020)

    11.4 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast

    11.5 The Influence of COVID-19 on Asia Pacific Market

    11.6 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis by Country

    11.6.1 China Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate
    11.6.2 Japan Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate
    11.6.3 South Korea Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate
    11.6.4 Australia Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate
    11.6.5 India Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate

    12 South America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis

    12.1 Market Overview and Prospect Analysis

    12.2 South America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Sales and Growth Rate (2015-2020)

    12.3 South America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue and Growth Rate (2015-2020)

    12.4 South America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast

    12.5 The Influence of COVID-19 on South America Market

    12.6 South America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis by Country

    12.6.1 Brazil Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate
    12.6.2 Argentina Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate
    12.6.3 Columbia Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate

    13 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis

    13.1 Market Overview and Prospect Analysis

    13.2 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Sales and Growth Rate (2015-2020)

    13.3 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue and Growth Rate (2015-2020)

    13.4 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast

    13.5 The Influence of COVID-19 on Middle East and Africa Market

    13.6 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis by Country

    13.6.1 UAE Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate
    13.6.2 Egypt Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate
    13.6.3 South Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate

    14 Conclusions and Recommendations

    14.1 Key Market Findings and Prospects

    14.2 Advice for Investors


    15 Appendix

    15.1 Methodology

    15.2 Research Data Source


    List of Tables and Figures
    Figure Product Picture
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size and Growth Rate 2015-2025
    Table Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Key Market Segments
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue ($) Segment by Type from 2015-2020
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue ($) Segment by Applications from 2015-2020
    Table SWOT Analysis
    Figure Global COVID-19 Status
    Figure Supply Chain
    Table Major Players Headquarters, and Service Area of Pharmaceutical Contract Development and Manufacturing Organization (CDMO)
    Table Major Players Revenue in 2019
    Figure Major Players Revenue Share in 2019
    Table Pharmaceutical Product Development LLC Company Profile
    Table Pharmaceutical Product Development LLC Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
    Figure Pharmaceutical Product Development LLC Production and Growth Rate
    Figure Pharmaceutical Product Development LLC Market Revenue ($) Market Share 2015-2020
    Table Pfizer CentreSource Company Profile
    Table Pfizer CentreSource Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
    Figure Pfizer CentreSource Production and Growth Rate
    Figure Pfizer CentreSource Market Revenue ($) Market Share 2015-2020
    Table Aenova Holding GmbH Company Profile
    Table Aenova Holding GmbH Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
    Figure Aenova Holding GmbH Production and Growth Rate
    Figure Aenova Holding GmbH Market Revenue ($) Market Share 2015-2020
    Table Jubilant Life Sciences Ltd. Company Profile
    Table Jubilant Life Sciences Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
    Figure Jubilant Life Sciences Ltd. Production and Growth Rate
    Figure Jubilant Life Sciences Ltd. Market Revenue ($) Market Share 2015-2020
    Table LSK Global Pharma Service Co Ltd. Company Profile
    Table LSK Global Pharma Service Co Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
    Figure LSK Global Pharma Service Co Ltd. Production and Growth Rate
    Figure LSK Global Pharma Service Co Ltd. Market Revenue ($) Market Share 2015-2020
    Table Patheon Inc. Company Profile
    Table Patheon Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
    Figure Patheon Inc. Production and Growth Rate
    Figure Patheon Inc. Market Revenue ($) Market Share 2015-2020
    Table Catalent Inc. Company Profile
    Table Catalent Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
    Figure Catalent Inc. Production and Growth Rate
    Figure Catalent Inc. Market Revenue ($) Market Share 2015-2020
    Table Recipharm AB Company Profile
    Table Recipharm AB Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
    Figure Recipharm AB Production and Growth Rate
    Figure Recipharm AB Market Revenue ($) Market Share 2015-2020
    Table Baxter Biopharma Solutions Company Profile
    Table Baxter Biopharma Solutions Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
    Figure Baxter Biopharma Solutions Production and Growth Rate
    Figure Baxter Biopharma Solutions Market Revenue ($) Market Share 2015-2020
    Table Lonza Group Company Profile
    Table Lonza Group Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
    Figure Lonza Group Production and Growth Rate
    Figure Lonza Group Market Revenue ($) Market Share 2015-2020
    Table Novotech Pty Ltd. Company Profile
    Table Novotech Pty Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
    Figure Novotech Pty Ltd. Production and Growth Rate
    Figure Novotech Pty Ltd. Market Revenue ($) Market Share 2015-2020
    Table Boehringer Ingelheim Group Company Profile
    Table Boehringer Ingelheim Group Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
    Figure Boehringer Ingelheim Group Production and Growth Rate
    Figure Boehringer Ingelheim Group Market Revenue ($) Market Share 2015-2020
    Table Covance Inc. Company Profile
    Table Covance Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
    Figure Covance Inc. Production and Growth Rate
    Figure Covance Inc. Market Revenue ($) Market Share 2015-2020
    Table Famar SA Company Profile
    Table Famar SA Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
    Figure Famar SA Production and Growth Rate
    Figure Famar SA Market Revenue ($) Market Share 2015-2020
    Table Syneos Health Inc. Company Profile
    Table Syneos Health Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
    Figure Syneos Health Inc. Production and Growth Rate
    Figure Syneos Health Inc. Market Revenue ($) Market Share 2015-2020
    Table PAREXEL International Corporation Company Profile
    Table PAREXEL International Corporation Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
    Figure PAREXEL International Corporation Production and Growth Rate
    Figure PAREXEL International Corporation Market Revenue ($) Market Share 2015-2020
    Table CMIC Holdings Co. Ltd Company Profile
    Table CMIC Holdings Co. Ltd Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
    Figure CMIC Holdings Co. Ltd Production and Growth Rate
    Figure CMIC Holdings Co. Ltd Market Revenue ($) Market Share 2015-2020
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales by Types (2015-2020)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales Share by Types (2015-2020)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue ($) by Types (2015-2020)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue Share by Types (2015-2020)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Price ($) by Types (2015-2020)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Sales by Types (2020-2025)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Sales Share by Types (2020-2025)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Revenue ($) by Types (2020-2025)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Revenue Share by Types (2020-2025)
    Figure Global Active Pharmaceutical Ingredient (API) Manufacturing Sales and Growth Rate (2015-2020)
    Figure Global Active Pharmaceutical Ingredient (API) Manufacturing Price (2015-2020)
    Figure Global Finished Dosage Formulation (FDF) Development Sales and Growth Rate (2015-2020)
    Figure Global Finished Dosage Formulation (FDF) Development Price (2015-2020)
    Figure Global and Manufacturing Sales and Growth Rate (2015-2020)
    Figure Global and Manufacturing Price (2015-2020)
    Figure Global Secondary Packaging Sales and Growth Rate (2015-2020)
    Figure Global Secondary Packaging Price (2015-2020)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue ($) and Growth Rate Forecast of Active Pharmaceutical Ingredient (API) Manufacturing (2020-2025)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate Forecast of Active Pharmaceutical Ingredient (API) Manufacturing (2020-2025)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue ($) and Growth Rate Forecast of Finished Dosage Formulation (FDF) Development (2020-2025)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate Forecast of Finished Dosage Formulation (FDF) Development (2020-2025)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue ($) and Growth Rate Forecast of and Manufacturing (2020-2025)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate Forecast of and Manufacturing (2020-2025)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue ($) and Growth Rate Forecast of Secondary Packaging (2020-2025)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate Forecast of Secondary Packaging (2020-2025)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales by Applications (2015-2020)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales Share by Applications (2015-2020)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue ($) by Applications (2015-2020)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue Share by Applications (2015-2020)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Sales by Applications (2020-2025)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Sales Share by Applications (2020-2025)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Revenue ($) by Applications (2020-2025)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Revenue Share by Applications (2020-2025)
    Figure Global Preclinical Sales and Growth Rate (2015-2020)
    Figure Global Preclinical Price (2015-2020)
    Figure Global Phase I Sales and Growth Rate (2015-2020)
    Figure Global Phase I Price (2015-2020)
    Figure Global Phase II Sales and Growth Rate (2015-2020)
    Figure Global Phase II Price (2015-2020)
    Figure Global Phase III Sales and Growth Rate (2015-2020)
    Figure Global Phase III Price (2015-2020)
    Figure Global Phase IV Sales and Growth Rate (2015-2020)
    Figure Global Phase IV Price (2015-2020)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue ($) and Growth Rate Forecast of Preclinical (2020-2025)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate Forecast of Preclinical (2020-2025)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue ($) and Growth Rate Forecast of Phase I (2020-2025)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate Forecast of Phase I (2020-2025)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue ($) and Growth Rate Forecast of Phase II (2020-2025)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate Forecast of Phase II (2020-2025)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue ($) and Growth Rate Forecast of Phase III (2020-2025)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate Forecast of Phase III (2020-2025)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue ($) and Growth Rate Forecast of Phase IV (2020-2025)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate Forecast of Phase IV (2020-2025)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Growth Rate (2015-2020)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales by Regions (2015-2020)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales Market Share by Regions (2015-2020)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales Market Share by Regions in 2019
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue and Growth Rate (2015-2020)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue by Regions (2015-2020)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue Market Share by Regions (2015-2020)
    Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue Market Share by Regions in 2019
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Sales by Regions (2020-2025)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Sales Share by Regions (2020-2025)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Revenue ($) by Regions (2020-2025)
    Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Revenue Share by Regions (2020-2025)
    Figure North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Sales and Growth Rate (2015-2020)
    Figure North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue and Growth Rate (2015-2020)
    Figure North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Sales (2020-2025)
    Figure North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Revenue ($) (2020-2025)
    Figure North America COVID-19 Status
    Figure U.S. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Sales and Growth Rate (2015-2020)
    Figure Canada Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Sales and Growth Rate (2015-2020)
    Figure Mexico

     

  • The Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
    By Companies / players:
      By Regions:
        By Type:
          By Application:
          Frequently asked questions(FAQ's):
          How are players chosen for the research coverage of the Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market study?

          MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.

          What is the current state of the Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Industry, and what is the projected growth trajectory through 2029?

          In 2023, the Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market share surpassed USD xx million, and between 2024 and 2029, it will grow at a CAGR of yy%.

          What challenges does the Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market face in the future?

          The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market across the extensive corporate landscape.

          What is the CAGR at which the Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market can expand?

          During the forecast years, the Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market can thrive with a robust CAGR.

          Our Clients